Form 4 for BIVI BIOVIE INC.
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-16 · accession 0001520138-23-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-22 | 2023-02-16 | BIVI | MARKHAM PENELOPE | EVP Liver Cirrhosis R, D | F - Tax | $6.12 | -2,476 | 47.8K | -5% | -$15.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2023-02-16 | F | D | 2,476 | $6.12 | 47,841 | D | — | — |